EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2: genes and variants

Explore variant evidence for EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 across 3 analyzed proteins (GABRB3, GABRG2, GABRA1). Linked ClinVar records include 80 pathogenic or likely pathogenic variants, 458 variants of uncertain significance and 74 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2

Where EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 variants cluster

ClinVar pathogenic and likely pathogenic variants linked to EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2

VariantPositionProtein partClinical label
GABRG2 R82Q82ExtracellularPathogenic / likely pathogenic (★★)
GABRG2 R82W82ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 D49N49ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 P253T253TransmembranePathogenic / likely pathogenic (★★)
GABRB3 S254F254TransmembranePathogenic / likely pathogenic (★★)
GABRG2 R323Q323ExtracellularPathogenic / likely pathogenic (★★)
GABRG2 Y331C331ExtracellularPathogenic / likely pathogenic (★★)
GABRA1 T289A289TransmembranePathogenic / likely pathogenic (★★)
GABRB3 L52V52ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 R232Q232ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 P301L301ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 Y302C302ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 K304R304ExtracellularPathogenic / likely pathogenic (★★)
GABRG2 T310I310TransmembranePathogenic / likely pathogenic (★★)
GABRG2 S325L325ExtracellularPathogenic / likely pathogenic (★★)
GABRA1 R147Q147ExtracellularPathogenic / likely pathogenic (★★)
GABRG2 G257R257ExtracellularPathogenic / likely pathogenic (★★)
GABRA1 R214C214ExtracellularPathogenic / likely pathogenic (★★)
GABRA1 T295I295TransmembranePathogenic / likely pathogenic (★★)
GABRB3 Y99C99ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 D120N120ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 L124F124ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 Y184C184ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 T185I185ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 I280F280TransmembranePathogenic / likely pathogenic (★★)
GABRB3 T288I288TransmembranePathogenic / likely pathogenic (★★)
GABRG2 T90M90ExtracellularPathogenic / likely pathogenic (★★)
GABRG2 N167K167ExtracellularPathogenic / likely pathogenic (★★)
GABRG2 P282S282TransmembranePathogenic / likely pathogenic (★★)
GABRG2 V287I287TransmembranePathogenic / likely pathogenic (★★)
GABRG2 G354V354TransmembranePathogenic / likely pathogenic (★★)
GABRG2 R363Q363CytoplasmicPathogenic / likely pathogenic (★★)
GABRG2 N72K72ExtracellularPathogenic / likely pathogenic (★★)
GABRB3 D49G49ExtracellularPathogenic / likely pathogenic (★)
GABRB3 T156I156ExtracellularPathogenic / likely pathogenic (★)
GABRB3 T156N156ExtracellularPathogenic / likely pathogenic (★)
GABRB3 P253H253TransmembranePathogenic / likely pathogenic (★)
GABRB3 S254Y254TransmembranePathogenic / likely pathogenic (★)
GABRG2 R82L82ExtracellularPathogenic / likely pathogenic (★)
GABRG2 R323G323ExtracellularPathogenic / likely pathogenic (★)
GABRA1 T292I292TransmembranePathogenic / likely pathogenic (★)
GABRG2 T311A311TransmembranePathogenic / likely pathogenic (★)
GABRA1 E277G277CytoplasmicPathogenic / likely pathogenic (★)
GABRB3 T157M157ExtracellularPathogenic / likely pathogenic (★)
GABRB3 R232P232ExtracellularPathogenic / likely pathogenic (★)
GABRB3 L256V256TransmembranePathogenic / likely pathogenic (★)
GABRB3 K299Q299ExtracellularPathogenic / likely pathogenic (★)
GABRB3 I306T306TransmembranePathogenic / likely pathogenic (★)
GABRG2 P83L83ExtracellularPathogenic / likely pathogenic (★)
GABRG2 A300T300CytoplasmicPathogenic / likely pathogenic (★)
GABRG2 A303T303TransmembranePathogenic / likely pathogenic (★)
GABRG2 S306F306TransmembranePathogenic / likely pathogenic (★)
GABRG2 T314S314TransmembranePathogenic / likely pathogenic (★)
GABRG2 I321T321TransmembranePathogenic / likely pathogenic (★)
GABRG2 R363G363CytoplasmicPathogenic / likely pathogenic (★)
GABRG2 R125H125ExtracellularPathogenic / likely pathogenic (★)
GABRG2 A334V334ExtracellularPathogenic / likely pathogenic (★)
GABRA1 F42L42ExtracellularPathogenic / likely pathogenic (★)
GABRA1 F92S92ExtracellularPathogenic / likely pathogenic (★)
GABRA1 A188D188ExtracellularPathogenic / likely pathogenic (★)

Showing 60 of 80.

Uncertain variants prioritized for review in EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2

VariantPositionProtein partClinical labelEvidence
GABRG2 A334T334ExtracellularConflicting reports (★)+7: 2 other pathogenic changes within 3 positions; A334V at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.824
GABRG2 T314K314TransmembraneConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; T314S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GABRG2 P83T83ExtracellularConflicting reports (★)+6: 4 other pathogenic changes within 3 positions; P83L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GABRB3 T288A288TransmembraneConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; T288I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97
GABRB3 K127R127ExtracellularConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; K127E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.58
GABRA1 R214S214ExtracellularConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R214C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.88
GABRG2 Y331N331ExtracellularUncertain (★)+6: 2 other pathogenic changes within 3 positions; Y331C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95
GABRB3 K304E304ExtracellularUncertain (★)+6: 4 other pathogenic changes within 3 positions; K304R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GABRG2 A300D300CytoplasmicUncertain (★)+6: 2 other pathogenic changes within 3 positions; A300T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GABRA1 N275S275CytoplasmicUncertain (★★)+6: 2 other pathogenic changes within 3 positions; N275K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.66
GABRB3 D49E49ExtracellularUncertain (★★)+6: 3 other pathogenic changes within 3 positions; D49G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GABRA1 E277D277CytoplasmicUncertain (★)+6: 3 other pathogenic changes within 3 positions; E277G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97
GABRB3 T185P185ExtracellularUncertain (★)+6: 2 other pathogenic changes within 3 positions; T185I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.86

Which prediction tools work for EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2

Frequently asked questions

Which genes have records linked to EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2?

This view contains 3 analyzed proteins: GABRB3, GABRG2, GABRA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 80 pathogenic or likely pathogenic variants, 458 variants of uncertain significance and 74 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 13 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 649 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center